// App-Quantinova.ai

DXT56 : Potential Weight Changes Among Patients with Multiple Sclerosis Undergoing Treatment with Ocrevus (Ocrelizumab)

Researchers

Presenter

  • Olivia Wei

Principal Investigators

  • Elizabeth S Gromisch

  • Lindsay O Neto

  • Jennifer A. Ruiz

  • Peter Wade

Medical Centers

  • Mount Sinai Rehabilitation Hospital, Trinity Health Of New England University of Connecticut School of Medicine Frank H. Netter MD School of Medicine at Quinnipiac University

  • University of Connecticut School of Medicine Mount Sinai Rehabilitation Hospital, Trinity Health Of New England

  • Frank Netter MD School of Medicine at Quinnipiac University, Hamden, CT

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Dermatology

  • Genetic Disorder

Disease

  • Multiple Sclerosis

  • Ectodermal dysplasia-syndactyly syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Ocrelizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved